Skip to main content

Table 6 Frequency of each criterion of MS according to ATP III and IDF in women with and without clinical lipodystrophy

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

Women
ATPIII IDF
MS criteria Total Without CL With CL p Total Without CL With CL p
WC [n, (%)] 61 (57.5%) 37 (68.5%) 24 (46.2%) 0.020 83 (78.3%) 45 (83.3%) 38 (73.1%) 0.200
TG [n, (%)] 78 (73.6%) 33 (61.1%) 45 (86.5%) 0.003 78 (73.6%) 33 (61.1%) 45 (86.5%) 0.003
HDL [n, (%)] 72 (67.9%) 31 (57.4%) 41 (78.8%) 0.018 72 (67.9%) 31(57.4%) 41 (78.8%) 0.018
BP [n, (%)] 37 (34.9%) 20 (37.0%) 17 (32.7%) 0.639 37 (34.9%) 20 (37.0%) 17 (32.7%) 0.639
GLU [n, (%)] 28 (26.4%) 16 (29.6%) 12 (23.1%) 0.444 28 (26.4%) 16 (29.6%) 12 (23.1%) 0.444
Number of MS criteria         
0 7 (6.6) 3 (5.6) 4 (7.7) 0.680 6 (5.7) 2 (3.7) 4 (7.7) 0.214
1 15 (14.2) 10 (18.5) 5 (9.6)   12 (11.3) 8 (14.8) 4 (7.7)  
2 34 (32.1) 16 (29.6) 18 (34.6)   26 (24.5) 16 (29.6) 10 (19.2)  
3 16 (15.1) 8 (14.8) 8 (15.4)   25 (23.6) 10 (18.5) 15 (28.8)  
4 25 (23.6) 14 (25.9) 11 (21.2)   26 (24.5) 15 (27.8) 11 (21.2)  
5 9 (8.5) 3 (5.6) 6 (11.5)   11 (10.4) 3 (5.6) 8 (15.4)  
  1. Note - CL = Clinical lipodystrophy MS = Metabolic syndrome; ATPIII = Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults; IDF = International Diabetes Federation; WC = waist circumference; TG = triglycerides; HDL = HDL cholesterol; BP = blood pressure; GLU = glucose.